Cirrhosis and liver transplantation in patients co-infected with HIV and hepatitis B or C: an observational cohort study

被引：0
|
作者：
Charlotte Warren-Gash
Kate Childs
Alicia Thornton
Sanjay Bhagani
Shirin Demma
Ankur Srivastava
Clifford Leen
Kosh Agarwal
Alison J. Rodger
Caroline A. Sabin
机构：
[1] University College London,Institute of Health Informatics
[2] King’s College Hospital,Institute of Liver Studies
[3] University College London,Research Department of Infection and Population Health
[4] Royal Free London NHS Foundation Trust,Department of Infectious Diseases
[5] University College London,Institute for Liver and Digestive Health, Division of Medicine
[6] University of Catania,Hepatology Unit, Department of Experimental and Clinical Medicine
[7] Western General Hospital,Regional Infectious Diseases Unit
[8] The Farr Institute of Health Informatics Research,undefined
来源：
Infection | 2017年 / 45卷
关键词：
HIV; Hepatitis B; Hepatitis C; Co-infection; Cirrhosis; Liver transplantation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
This study assessed the likelihood of referral for liver transplantation assessment in a prospective cohort of patients co-infected with HIV and hepatitis B or C with complications of cirrhosis. There were 141 co-infected patients from 11 UK centres with at least one complication of cirrhosis recorded (either decompensation or hepatocellular carcinoma) out of 772 identified with cirrhosis and/or HCC. Only 23 of these 141 (16.3%) were referred for liver transplantation assessment, even though referral is recommended for co-infected patients after the first decompensation episode.
引用
收藏
页码：215 / 220
页数：5
相关论文
共 50 条
  • [41] Hepatocellular cancer in Swedish hepatitis B patients and in hepatitis C co-infected patients
    Daviosdottir, Loa
    Duberg, Ann-Sofi
    Aleman, Soo
    Torner, Anna
    Back, Erik
    Ekdahl, Karl
    Blaxhult, Anders
    Hultcrantz, Rolf
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2007, 42 : 14 - 14
  • [42] Use of Telaprevir to Treat Hepatitis C Recurrence aft er Liver Transplantation in an HIV Co-infected Patient
    Singh, Gurshawn
    Carey, William
    Zein, Nizar
    Taege, Alan
    Alkhouri, Naim
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S355 - S355
  • [43] The Successful Use of Telaprevir to Treat Hepatitis C Recurrence After Liver Transplantation in an HIV Co-Infected Patient
    Alkhouri, Naim
    Singh, Gurshawn
    Carey, William D.
    Fung, John J.
    Zein, Nizar N.
    Eghtesad, Bijan
    Taege, Alan
    TRANSPLANTATION, 2014, 97 (02) : E14 - E15
  • [44] Specific risks of liver transplantation in patients co-infected with hepatitis C virus and human immunodeficiency virus
    Dumortier, J
    Chiarello, P
    Adham, M
    Delafosse, B
    Chayvialle, JA
    Scoazec, JY
    Boillot, O
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2002, 26 (11): : 1061 - 1062
  • [45] Evidence of Distinct Populations of Hepatitis C Virus in the Liver and Plasma of Patients Co-Infected With HIV and HCV
    Blackard, Jason T.
    Ma, Gang
    Sengupta, Satarupa
    Martin, Christina M.
    Powell, Eleanor A.
    Shata, M. Tarek
    Sherman, Kenneth E.
    JOURNAL OF MEDICAL VIROLOGY, 2014, 86 (08) : 1332 - 1341
  • [46] Cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIV
    Campos, Nicole G.
    Salomon, Joshua A.
    Servoss, Julie C.
    Nunes, David P.
    Samet, Jeffrey H.
    Freedberg, Kenneth A.
    Goldie, Sue J.
    AMERICAN JOURNAL OF MEDICINE, 2007, 120 (03): : 272 - 279
  • [47] The need to exercise caution in the management of patients co-infected with HIV and hepatitis B
    Joseph, AT
    Chandramani, S
    Cox, M
    INTERNATIONAL JOURNAL OF STD & AIDS, 2000, 11 (02) : 131 - 132
  • [48] Anti-Hepatitis C (HCV) Triple Therapy With Protease Inhibitors in HIV/HCV Co-Infected Patients after Liver Transplantation
    Antonini, T. M.
    Furlan, V.
    Teicher, E.
    Haim-Boukobza, S.
    Sebagh, M.
    Coilly, A.
    Bonhomme-Faivre, L.
    Roque-Afonso, A. M.
    Vittecoq, D.
    Samuel, D.
    Taburet, A. M.
    Duclos-Vallee, J. C.
    LIVER TRANSPLANTATION, 2014, 20 : S169 - S170
  • [49] ANTI-HEPATITIS C (HCV) TRIPLE THERAPY WITH PROTEASE INHIBITORS IN HIV/HCV CO-INFECTED PATIENTS AFTER LIVER TRANSPLANTATION
    Antonini, T. M.
    Furlan, V.
    Teicher, E.
    Haim-Boukobza, S.
    Sebagh, M.
    Coilly, A.
    Bonhomme-Faivre, L.
    Roque-Afonso, A. -M.
    Vittecoq, D.
    Samuel, D.
    Taburet, A. -M.
    Duclos-Vallee, J. -C.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S501 - S501
  • [50] Faldaprevir (BI 201335) for the treatment of hepatitis C in patients co-infected with HIV
    Lorna Laufer, Natalia
    Rockstroh, Juergen Kurt
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2014, 12 (02) : 157 - 164
12345